• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大豆异黄酮染料木黄酮通过微小RNA和葡萄糖代谢调节增强乳腺癌对他莫昔芬的敏感性。

Soy Isoflavone Genistein Enhances Tamoxifen Sensitivity in Breast Cancer via microRNA and Glucose Metabolism Modulation.

作者信息

Shpigel Jessica, Luciano Emilia F, Ukandu Blessing, Sauane Moira, de la Parra Columba

机构信息

Department of Chemistry, Herbert H. Lehman College, City University of New York, New York, NY 10468, USA.

Department of Biological Sciences, Herbert H. Lehman College, City University of New York, New York, NY 10468, USA.

出版信息

Int J Mol Sci. 2025 Jan 16;26(2):733. doi: 10.3390/ijms26020733.

DOI:10.3390/ijms26020733
PMID:39859445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11765730/
Abstract

Breast cancer treatment has advanced significantly, particularly for estrogen receptor-positive (ER+) tumors. Tamoxifen, an estrogen antagonist, is widely used; however, approximately 40% of patients develop resistance. Recent studies indicate that microRNAs, especially miR-155, play a critical role in this resistance. Our analysis of MCF-7 tamoxifen-sensitive (TAM-S) and tamoxifen-resistant (TAM-R) cells revealed that miR-155 is significantly upregulated in TAM-R cells. Overexpression of miR-155 in TAM-S cells increased resistance to tamoxifen. Additionally, genistein, a natural isoflavone from soybeans, effectively downregulated miR-155 and its targets associated with apoptosis and glucose metabolism, including STAT3 and hexokinase 2 (HK2). Notably, genistein also significantly decreased cell migration, suggesting potential anti-metastatic effects. Furthermore, genistein reduced glucose consumption, indicating its potential to overcome miR-155-mediated tamoxifen resistance and modulate the Warburg effect. These findings highlight genistein as a promising therapeutic agent for overcoming tamoxifen resistance in ER+ breast cancer and merit further investigation.

摘要

乳腺癌治疗已经取得了显著进展,尤其是对于雌激素受体阳性(ER+)肿瘤。他莫昔芬作为一种雌激素拮抗剂被广泛使用;然而,约40%的患者会产生耐药性。最近的研究表明,微小RNA,尤其是miR-155,在这种耐药性中起关键作用。我们对MCF-7他莫昔芬敏感(TAM-S)和他莫昔芬耐药(TAM-R)细胞的分析显示,miR-155在TAM-R细胞中显著上调。在TAM-S细胞中过表达miR-155会增加对他莫昔芬的耐药性。此外,染料木黄酮,一种来自大豆的天然异黄酮,有效地下调了miR-155及其与细胞凋亡和糖代谢相关的靶标,包括信号转导和转录激活因子3(STAT3)和己糖激酶2(HK2)。值得注意的是,染料木黄酮还显著降低了细胞迁移,表明其具有潜在的抗转移作用。此外,染料木黄酮减少了葡萄糖消耗,表明其有潜力克服miR-155介导的他莫昔芬耐药性并调节瓦伯格效应。这些发现突出了染料木黄酮作为克服ER+乳腺癌中他莫昔芬耐药性的一种有前景的治疗剂,值得进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b07/11765730/56861a7871c2/ijms-26-00733-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b07/11765730/7ec7fe0e2638/ijms-26-00733-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b07/11765730/eb5c42aabda1/ijms-26-00733-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b07/11765730/36e0b900ef31/ijms-26-00733-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b07/11765730/56861a7871c2/ijms-26-00733-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b07/11765730/7ec7fe0e2638/ijms-26-00733-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b07/11765730/eb5c42aabda1/ijms-26-00733-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b07/11765730/36e0b900ef31/ijms-26-00733-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b07/11765730/56861a7871c2/ijms-26-00733-g004.jpg

相似文献

1
Soy Isoflavone Genistein Enhances Tamoxifen Sensitivity in Breast Cancer via microRNA and Glucose Metabolism Modulation.大豆异黄酮染料木黄酮通过微小RNA和葡萄糖代谢调节增强乳腺癌对他莫昔芬的敏感性。
Int J Mol Sci. 2025 Jan 16;26(2):733. doi: 10.3390/ijms26020733.
2
Tinagl1 restores tamoxifen sensitivity and blocks fibronectin-induced EMT by simultaneously blocking the EGFR and β1-integrin/FAK signaling pathways in tamoxifen-resistant breast cancer cells.Tinagl1可恢复他莫昔芬敏感性,并通过同时阻断他莫昔芬耐药乳腺癌细胞中的表皮生长因子受体(EGFR)和β1整合素/黏着斑激酶(FAK)信号通路,来阻止纤连蛋白诱导的上皮-间质转化(EMT)。
IUBMB Life. 2025 Jan;77(1):e2940. doi: 10.1002/iub.2940.
3
miRNAs as emerging predictors of tamoxifen resistance in breast cancer.微小RNA作为乳腺癌中他莫昔芬耐药性的新兴预测指标
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 5. doi: 10.1007/s00210-025-03936-z.
4
SLC31A1 promotes chemoresistance through inducing CPT1A-mediated fatty acid oxidation in ER-positive breast cancer.溶质载体家族31成员1(SLC31A1)通过诱导内质网阳性乳腺癌中肉碱/有机阳离子转运体1A(CPT1A)介导的脂肪酸氧化促进化疗耐药。
Neoplasia. 2025 Mar;61:101125. doi: 10.1016/j.neo.2025.101125. Epub 2025 Feb 3.
5
EGR3 and estrone are involved in the tamoxifen resistance and progression of breast cancer.EGR3 和雌酮参与了乳腺癌的他莫昔芬耐药和进展。
J Cancer Res Clin Oncol. 2023 Dec;149(20):18103-18117. doi: 10.1007/s00432-023-05503-6. Epub 2023 Nov 24.
6
Genistein-Chitosan Derivative Nanoparticles for Targeting and Enhancing the Anti-Breast Cancer Effect of Tamoxifen In Vitro.金雀异黄素-壳聚糖衍生物纳米粒靶向增强他莫昔芬体外抗乳腺癌作用
J Pharm Sci. 2024 Aug;113(8):2575-2583. doi: 10.1016/j.xphs.2024.05.023. Epub 2024 May 25.
7
Thymoquinone-PLGA-PF68 Nanoparticles Induce S Phase Cell Cycle Arrest and Apoptosis, Leading to the Inhibition of Migration and Colony Formation in Tamoxifen-Resistant Breast Cancer Cells.百里醌-PLGA-PF68纳米颗粒诱导S期细胞周期停滞和凋亡,导致对他莫昔芬耐药的乳腺癌细胞迁移和集落形成受到抑制。
Curr Mol Med. 2025;25(6):760-772. doi: 10.2174/0115665240347014241203065055.
8
Cytokines-activated nuclear IKKα-FAT10 pathway induces breast cancer tamoxifen-resistance.细胞因子激活的核 IKKα-FAT10 通路诱导乳腺癌对他莫昔芬耐药。
Sci China Life Sci. 2024 Jul;67(7):1413-1426. doi: 10.1007/s11427-023-2460-0. Epub 2024 Apr 1.
9
ZMIZ1 lactylation induces tamoxifen resistance in breast cancer through increasing transcriptional activity of Nanog to impact cell stemness and cholesterol uptake.ZMIZ1 乳酸化通过增加 Nanog 的转录活性影响细胞干性和胆固醇摄取,从而诱导乳腺癌对他莫昔芬耐药。
Cell Biol Toxicol. 2025 Jul 16;41(1):117. doi: 10.1007/s10565-025-10068-w.
10
Metabolomic Profiling Reveals Key Metabolic Alterations in MCF7 Tamoxifen-Resistant Cells Following EPAS1 Inhibition.
J Proteome Res. 2025 Aug 1;24(8):4070-4081. doi: 10.1021/acs.jproteome.5c00170. Epub 2025 Jul 17.

本文引用的文献

1
Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer.原发性和转移性乳腺癌中的代谢重编程和治疗抵抗。
Mol Cancer. 2024 Nov 21;23(1):261. doi: 10.1186/s12943-024-02165-x.
2
The Molecular Mechanisms behind Advanced Breast Cancer Metabolism: Warburg Effect, OXPHOS, and Calcium.晚期乳腺癌代谢的分子机制:瓦博格效应、OXPHOS 和钙。
Front Biosci (Landmark Ed). 2024 Mar 13;29(3):99. doi: 10.31083/j.fbl2903099.
3
MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies.微小 RNA:癌症诊断和治疗策略临床试验的趋势。
Exp Mol Med. 2023 Jul;55(7):1314-1321. doi: 10.1038/s12276-023-01050-9. Epub 2023 Jul 10.
4
MicroRNAs as regulators of tumor metabolism.微小 RNA 作为肿瘤代谢的调节因子。
Endocr Relat Cancer. 2023 Jul 18;30(8). doi: 10.1530/ERC-22-0267. Print 2023 Aug 1.
5
Soy Isoflavones Induce Cell Death by Copper-Mediated Mechanism: Understanding Its Anticancer Properties.大豆异黄酮通过铜介导的机制诱导细胞死亡:了解其抗癌特性。
Molecules. 2023 Mar 24;28(7):2925. doi: 10.3390/molecules28072925.
6
A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer.乳腺癌中雌激素受体信号通路的基础研究综述
Int J Mol Sci. 2023 Apr 6;24(7):6834. doi: 10.3390/ijms24076834.
7
MIR497HG-Derived miR-195 and miR-497 Mediate Tamoxifen Resistance via PI3K/AKT Signaling in Breast Cancer.MIR497HG 衍生的 miR-195 和 miR-497 通过 PI3K/AKT 信号通路介导乳腺癌对他莫昔芬的耐药性。
Adv Sci (Weinh). 2023 Apr;10(12):e2204819. doi: 10.1002/advs.202204819. Epub 2023 Feb 23.
8
The Roles of microRNAs in Cancer Multidrug Resistance.微小RNA在癌症多药耐药中的作用
Cancers (Basel). 2022 Feb 21;14(4):1090. doi: 10.3390/cancers14041090.
9
Genistein: A Review on its Anti-Inflammatory Properties.金雀异黄素:抗炎特性综述
Front Pharmacol. 2022 Jan 24;13:820969. doi: 10.3389/fphar.2022.820969. eCollection 2022.
10
Genistein: A Potent Anti-Breast Cancer Agent.染料木黄酮:一种强效的抗乳腺癌制剂。
Curr Issues Mol Biol. 2021 Oct 10;43(3):1502-1517. doi: 10.3390/cimb43030106.